相关实验视频

Updated: Jun 19, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

格洛菲他马布作为B细胞淋巴瘤的救援治疗在现实世界中:台湾的一项多中心研究

Ya-Ting Hsu1, Shang-Ju Wu2, Hsiao-Wen Kao3

  • 1Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Cancer
|February 2, 2024
PubMed
概括

格洛菲他马布在复发/耐药B细胞淋巴瘤中显示出现实世界的有效性,与临床试验相比. 这种双特异性抗体表现出持久的反应和可管理的安全性,包括B型肝炎病毒患者.

关键词:
在B细胞淋巴瘤.两种特异性抗体的抗体环球Fitamabb是什么意思现实世界的数据数据.

更多相关视频

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.1K
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K

相关概念视频

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...